Address
2430 North Halsted Street
Chicago, IL 60614
United States of America (the)
Phone
847 673 1700
Website
Sector
Healthcare
Industry
Biotechnology
Employees
7
First IPO Date
May 22, 2018
| Name | Title | Pay | Year Born |
| Jungsoo Kim | Chief Executive Officer, President & Director | 777,167 | 1973 |
| Joshua Miller | Chief Accounting Officer | 0 | 1977 |
| Devki Sukhtankar | Head of Preclinical Research & Translational Medicine | 0 | N/A |
| Niña Caculitan | Head of Clinical | 0 | N/A |
| Gyuyeob Lee | Interim CFO & Secretary | 0 | 1986 |
| Young Seung Ko | Chief Operating Officer | 0 | 1976 |
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partnership with AbbVie Inc. to advance SNA-based solutions for various hair loss conditions, under a collaboration, option, and license agreement. Additionally, a separate collaborative effort with Ipsen S.A. aims to investigate, develop, and commercialize novel spherical nucleic acids targeting Huntington's disease and Angelman syndrome. Established in 2011, Exicure's corporate base is located in Chicago, Illinois.